市場調查報告書
商品編碼
1468329
2024-2032 年血液透析市場報告(按細分市場、模式、最終用戶和地區)Hemodialysis Market Report by Segment, Modality, End-User, and Region 2024-2032 |
IMARC Group年,全球血液透析市場規模達907億美元。醫療保健提供者和透析製造商之間日益加強的合作促進了治療的可用性、高血壓相關腎臟疾病患病率的上升、器官可用性的有限、對腎臟疾病的認知不斷增強以及改善透析機會的倡導是推動市場發展的一些因素。
血液透析是一種挽救生命的醫療程序,用於治療晚期腎臟病或腎衰竭患者。當腎臟無法再有效地執行這些功能時,它涉及使用一種稱為透析器的專用機器來清除血液中的廢物、多餘的液體和電解質。在血液透析過程中,患者的血液會透過血管接入點(通常是手術創建的瘻管或移植物)從身體轉移到透析器。血液經由透析器內的半透膜過濾,使廢物和多餘物質從血液中排出並進入透析液中。過濾後的血液隨後回到患者體內。血液透析通常持續幾個小時,並且通常每週進行多次。頻率和持續時間取決於患者的特定醫療狀況及其醫療保健提供者的建議。它在維持人體液體和電解質平衡、有效控制血壓以及防止有害廢物累積方面發揮著至關重要的作用,否則會導致嚴重的健康併發症。雖然血液透析是一種要求很高且通常是終生的治療方法,但它可以顯著提高腎衰竭患者的生活品質和壽命。
全球市場主要是由慢性腎臟疾病發生率的增加所推動的。與此一致的是,不斷成長的老齡化人口更容易出現腎臟相關問題,從而導致對血液透析的需求更高。此外,全球糖尿病流行顯著導致腎臟疾病病例增加,需要進行血液透析。除此之外,與肥胖相關的腎臟疾病刺激了對血液透析治療的需求。此外,醫療設施的改善也導致腎臟疾病的診斷和治療增加。透析機和程序的技術創新提高了治療效率。此外,人們對腎臟健康的認知不斷提高,鼓勵早期介入和透析。此外,優惠的報銷政策使患者能夠負擔得起血液透析治療費用。
增加醫療旅遊
醫療旅遊的蓬勃發展正在刺激市場。擁有先進醫療設施和較低治療成本的國家吸引尋求高品質血液透析服務的患者。醫療遊客通常會選擇可以獲得專門護理(包括血液透析)的地區,而費用只是他們在本國的一小部分。國際患者的湧入需要建立設備齊全的透析中心來滿足他們的需求。醫療旅遊中心的醫療保健提供者擴大了透析能力,僱用熟練的專業人員,並採用先進技術來滿足不斷成長的需求。隨著醫療旅遊的持續成長,由於外出尋求治療的患者數量增加,市場出現成長。
擴建全球透析中心
透析中心的全球擴張對於推動市場至關重要。隨著更多的透析設施在不同地區建立,獲得血液透析治療的機會變得更加普遍。這些中心確保腎臟病患者能夠方便且及時地獲得維持生命的血液透析程序。擴大的透析中心網路不僅可以容納不斷成長的患者群體,還有助於早期診斷和介入。這種擴張透過為需要定期血液透析的個人創造一個更方便、以患者為中心的環境來推動市場成長。此外,更廣泛的透析中心的存在促進了競爭,從而鼓勵了技術進步和服務改進,提高了所提供護理的整體品質並刺激了對血液透析服務的需求。
腎臟科醫生短缺
腎臟病專家的短缺正在提振市場。由於能夠處理不斷增加的腎臟疾病病例的腎臟科醫生越來越少,對血液透析服務的需求也在增加。為了解決這種短缺問題,醫療保健提供者擴大了血液透析服務,開設了新的中心並提高了治療能力。這種現像也鼓勵遠距醫療解決方案的開發和實施,實現血液透析患者的遠距會診和監測。此外,短缺促使醫療機構投資於醫療專業人員的培訓和技能提升計劃,以解決腎臟病護理方面的缺口。這種應對腎病專家短缺的合作努力導致了血液透析治療的更廣泛的可用性,最終推動市場的成長,因為越來越多的患者依靠這些服務來有效地管理他們的腎臟健康。
The global hemodialysis market size reached US$ 90.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 126.7 Billion by 2032, exhibiting a growth rate (CAGR) of 3.7% during 2024-2032. The increasing collaborations between healthcare providers and dialysis manufacturers promote treatment availability, the rising prevalence of hypertension-related kidney diseases, the limited organ availability, the growing awareness about kidney diseases, and advocacy for improved dialysis access are some of the factors propelling the market.
Hemodialysis is a life-saving medical procedure for treating individuals with advanced kidney disease or kidney failure. It involves using a specialized machine called a dialyzer to remove waste, excess fluids, and electrolytes from the blood when the kidneys can no longer perform these functions effectively. During hemodialysis, a patient's blood is diverted from their body through a vascular access point (usually a surgically created fistula or graft) to the dialyzer. The blood is filtered through a semipermeable membrane within the dialyzer, allowing waste and excess substances to pass out of the blood and into a dialysate solution. The filtered blood is then returned to the patient's body. Hemodialysis sessions typically last several hours and are generally performed multiple times a week. The frequency and duration depend on the patient's specific medical condition and the advice of their healthcare provider. It plays a crucial role in maintaining the body's balance of fluids and electrolytes, effectively managing blood pressure, and preventing the accumulation of harmful waste products that would otherwise lead to serious health complications. While it is a demanding and often lifelong treatment, hemodialysis significantly enhances the quality of life and longevity of individuals with kidney failure.
The global market is majorly driven by the increasing incidence of chronic kidney diseases. In line with this, the rising aging population is more susceptible to kidney-related issues, leading to a higher need for hemodialysis. Furthermore, the global diabetes epidemic contributes significantly to kidney disease cases, necessitating hemodialysis. Apart from this, obesity-related kidney diseases fuel the demand for hemodialysis treatments. Moreover, better access to medical facilities has led to increased diagnosis and treatment of kidney diseases. Technological innovations in dialysis machines and procedures improve treatment efficiency. Besides, the escalating awareness about kidney health encourages early intervention and dialysis. Additionally, favorable reimbursement policies enable patients to afford hemodialysis treatments.
Increasing medical tourism
The growing trend of medical tourism is stimulating the market. Countries with advanced healthcare facilities and lower treatment costs attract patients seeking high-quality hemodialysis services. Medical tourists often choose regions where they can access specialized care, including hemodialysis, at a fraction of the cost they would incur in their home countries. This influx of international patients necessitates the establishment of well-equipped dialysis centers to cater to their needs. Healthcare providers in medical tourism hubs expand their dialysis capacities, employ skilled professionals, and adopt advanced technologies to accommodate the rising demand. As medical tourism continues to rise, the market experiences growth due to the increased volume of patients seeking treatment away from home.
Expansion of dialysis centers worldwide
The global expansion of dialysis centers is pivotal in propelling the market. With more dialysis facilities being established across different regions, access to hemodialysis treatments becomes more widespread. These centers ensure patients with kidney diseases have convenient and timely access to life-sustaining hemodialysis procedures. The expanded network of dialysis centers not only accommodates the growing patient population and facilitates early diagnosis and intervention. This expansion drives market growth by creating a more accessible and patient-centered environment for individuals needing regular hemodialysis sessions. Furthermore, the presence of a broader range of dialysis centers fosters competition, which, in turn, encourages technological advancements and service improvements, enhancing the overall quality of care provided and fueling the demand for hemodialysis services.
Shortage of nephrologists
The shortage of nephrologists is bolstering the market. With fewer nephrologists available to manage the increasing number of kidney disease cases, the demand for hemodialysis services increases. To address this scarcity, healthcare providers expand their hemodialysis offerings, opening new centers and increasing treatment capacities. This phenomenon also encourages the development and implementation of telemedicine solutions, enabling remote consultations and monitoring of hemodialysis patients. Additionally, the shortage prompts healthcare institutions to invest in training and upskilling programs for medical professionals to address the gap in nephrology care. This collaborative effort to cope with the nephrologist shortage results in the wider availability of hemodialysis treatments, ultimately driving the market's growth as more patients rely on these services to manage their kidney health effectively.
IMARC Group provides an analysis of the key trends in each segment of the global hemodialysis market report, along with forecasts at the global and regional levels from 2024-2032. Our report has categorized the market based on segment, modality, and end-user.
Hemodialysis Product
Machines
Dialyzers
Others
Hemodialysis Service
In-center Services
Home Services
Hemodialysis service dominates the market
The report has provided a detailed breakup and analysis of the market based on the segment. This includes hemodialysis product (machines, dialyzers, and others) and hemodialysis service (in-center services and home services). According to the report, hemodialysis service represented the largest segment.
The hemodialysis service segment is bolstering the market due to its essential role in delivering life-sustaining treatments to individuals with kidney diseases. As the prevalence of kidney-related conditions rises, the demand for hemodialysis services escalates. These services encompass a comprehensive range of treatments, including pre-dialysis assessments, dialysis sessions, post-treatment care, and patient education. The convenience of receiving expert care within specialized centers or even through home-based setups attracts patients seeking efficient and regular hemodialysis.
Moreover, the adoption of advanced technologies and personalized treatment plans within hemodialysis services enhances treatment effectiveness and patient outcomes. As healthcare providers continue to invest in expanding and refining their hemodialysis service offerings, the segment significantly contributes to market growth by ensuring accessible, quality care for patients dependent on these life-saving procedures.
Conventional Hemodialysis
Short Daily Hemodialysis
Nocturnal Hemodialysis
Conventional hemodialysis dominates the market
The report has provided a detailed breakup and analysis of the market based on the modality. This includes conventional hemodialysis, short daily hemodialysis, and nocturnal hemodialysis. According to the report, conventional hemodialysis represented the largest segment.
The conventional hemodialysis modality drives market growth due to its widespread adoption and established efficacy in treating kidney diseases. This modality involves using a dialysis machine to filter and cleanse the blood, removing waste and excess fluids. Its long-standing presence and familiarity in medical practice make it a preferred choice for patients and healthcare providers. As the prevalence of kidney diseases increases, the demand for effective treatment options escalates, leading to the continued prominence of conventional hemodialysis.
Additionally, technological advancements have improved dialysis machine efficiency, safety, and patient comfort. These enhancements further bolster the appeal of conventional hemodialysis as a reliable and proven method for managing kidney-related conditions, thereby contributing significantly to the market's overall growth.
Hospitals
Independent Dialysis Centres
Others
The report has provided a detailed breakup and analysis of the market based on the end-user. This includes hospitals, independent dialysis centres, and others.
Hospitals with advanced medical infrastructure and expert staff provide comprehensive hemodialysis services to multiple patients. Their ability to handle complex cases, offer integrated care, and provide emergency services contributes to the market's expansion.
On the other hand, independent dialysis centers offer specialized care focused solely on hemodialysis. These centers promote convenience and tailored treatment plans, catering to the specific needs of patients. Their growth stems from increased patient preference for outpatient care, flexibility, and proximity to home.
Both segments foster competition, encouraging advancements in treatment quality, technology, and patient experience. As demand for hemodialysis rises, the combined efforts of hospitals and independent centers ensure broader access to life-sustaining treatments, propelling the market forward and meeting the diverse needs of individuals with kidney diseases.
Asia Pacific
Europe
North America
Middle East and Africa
Latin America
North America exhibits a clear dominance, accounting for the largest hemodialysis market share
The report has also provided a comprehensive analysis of all the major regional markets, which include Asia Pacific, Europe, North America, Middle East and Africa, and Latin America. According to the report, North America was the largest market for hemodialysis.
The North American region is a significant driver of market growth due to its advanced healthcare infrastructure, increasing prevalence of kidney diseases, and heightened awareness about renal health. Well-established medical facilities and technological advancements enable the delivery of high-quality hemodialysis services. A rising aging population and lifestyle-related factors contribute to the growing incidence of kidney diseases, thereby propelling the demand for effective treatments like hemodialysis.
Moreover, North America's proactive healthcare policies and reimbursement systems facilitate patient access to these vital procedures. The region's emphasis on research and development leads to continuous improvements in hemodialysis techniques, equipment, and patient care. The partnership between healthcare institutions and industry players further accelerates innovation. The region's robust healthcare ecosystem, coupled with increasing patient needs, ensures the steady expansion of the market.
Top companies are strengthening the market through innovative products, strategic expansions, and commitment to improving patient outcomes. These companies invest in research and development, continuously introducing advanced dialysis machines, equipment, and solutions that enhance treatment effectiveness and patient comfort. Their focus on technological innovation, such as improved filtration systems and connectivity features, raises the quality of care. Moreover, these companies engage in strategic partnerships and acquisitions, expanding their global reach and enhancing their service portfolios. By collaborating with healthcare institutions and professionals, they facilitate the establishment of specialized dialysis centers and enable easier access to treatments. Additionally, top companies prioritize patient education and support, offering training programs and resources to medical staff and patients. This approach fosters awareness, adherence, and better management of kidney-related conditions, ultimately driving sustained market growth.
The report has provided a comprehensive analysis of the competitive landscape in the hemodialysis market. Detailed profiles of all major companies have also been provided.
Baxter International
Asahi Kasei Corporation
B. Barun Melsungen
DaVita
Cantel Medical Corporation
Fresenius Medical Care
Nipro Corporation
Rockwell Medical
Medivators
Toray Medical Company Ltd.
Nikkiso Co. Ltd.
Surni Group
Gambro
Satellite Healthcare Inc.
Renacon Pharma Ltd.
In 2020, Fresenius Medical Care expanded its home dialysis offerings, emphasizing the importance of home-based treatments during the COVID-19 pandemic. They also announced collaborations to enhance remote patient monitoring and telehealth services.
In 2020, Baxter introduced the SHARESOURCE 2 telehealth platform for Peritoneal Dialysis (PD) patients, enhancing remote patient management and communication between patients and healthcare providers.
In 2020, Asahi Kasei announced a partnership with BioPorto to distribute the NGAL Test, a diagnostic tool for the early detection of acute kidney injury, helping better patient management.